LIFE-B:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund UnHedged Units (CAD)

ETF | Others |

Last Closing

CAD 25.28

Change

0.00 (0.00)%

Market Cap

CAD 0.01B

Volume

1.43K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.02 (+0.07%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.03 (+0.06%)

CAD 5.37B
XEQT:CA iShares Core Equity Portfolio

+0.29 (+0.90%)

CAD 4.78B
PHYS-U:CA Sprott Physical Gold Trust

+0.02 (+0.10%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.40 (+1.12%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.15 (+1.40%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 2.53B

ETFs Containing LIFE-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.26% 54% F 53% F
Dividend Return 0.67% 51% F 24% F
Total Return 6.94% 55% F 50% F
Trailing 12 Months  
Capital Gain 8.45% 49% F 53% F
Dividend Return 2.06% 81% B- 44% F
Total Return 10.51% 54% F 51% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.00% 57% F 49% F
Dividend Return 2.14% 58% F 43% F
Total Return 0.14% 68% D+ 18% F
Risk Return Profile  
Volatility (Standard Deviation) 5.47% 68% D+ 86% B+
Risk Adjusted Return 39.09% 70% C- 61% D-
Market Capitalization 0.01B 23% F 10% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.